NF-κB transcription factors are involved in normal erythropoiesis

Blood

Volumn 91, Issue 11, 1998, Pages 4136-4144

  Zhang, Min Ying ^a   Sun, Shao Cong ^a   Bell, Laurie ^a   Miller, Barbara A ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR; DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TRANSCRIPTION FACTOR RELA;

ACUTE PHASE RESPONSE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMATION; DNA BINDING; ERYTHROLEUKEMIA; ERYTHROPOIESIS; GENETIC REGULATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN FAMILY; TATA BOX; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; DRUG EFFECT; ERYTHROID PRECURSOR CELL; METABOLISM; ONCOGENE MYC; PHYSIOLOGY; PROTO ONCOGENE;

CELL DIVISION; DNA; ERYTHROID PROGENITOR CELLS; ERYTHROPOIESIS; GENES, MYC; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROTO-ONCOGENES; TRANSCRIPTION FACTOR RELA; TUMOR CELLS, CULTURED;

EID: 0032081311     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.11.4136     Document Type: Article

References (49)

1. Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10:405, 1994
2. Liou H-C, Baltimore D: Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr Opin Cell Biol 5:477, 1993
3. Thanos D, Maniatis T: NF-κB: A lesson in family values. Cell 80:529, 1995
4. Beg AA, Baldwin AS: The IκB proteins: Multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev 7:2064, 1993
5. Ghosh S, Baltimore D: Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 344:678, 1990
6. Finco TS, Baldwin AS: Mechanistic aspects of NF-κB regulation: The emerging role of phosphorylation and proteolysis. Immunity 3:263, 1995
7. Grilli M, Chiu J J-S, Lenardo MJ: NF-κB and Rel: Participants in a multiform transcriptional regulatory system. Int Rev Cytol 143:1, 1993
8. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141, 1994
9. Beg AA, Baldwin AS: Activation of multiple NF-κB/Rel DNA-binding complexes by tumor necrosis factor. Oncogene 9:1487, 1994
10. Brach MA, Gruss H-J, Riedel D, Mertelsmann R, Herrmann F: Activation of NF-κB by interleukin 2 in human blood monocytes. Cell Growth Differ 3:421, 1992
11. Kang CD, Lee BK, Kim KW, Kim CM, Kim SH, Chung BS: Signaling mechanism of PMA-induced differentiation of K562 cells. Biochem Biophys Res Commun 221:95, 1996
12. Desiderio S: Transcription factors controlling B-cell development. Curr Biol 5:605, 1995
13. McDonald PP, Bald A, Cassatella MA: Activation of the NF-κB pathway by inflammatory stimuli in human neutrophils. Blood 89:3421, 1997
14. Duyao MP, Buckler AJ, Sonenshein GE: Interaction of an NF-κB-like factor with a site upstream of the c-myc promoter. Proc Natl Acad Sci USA 27:4727, 1990
15. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao Y-F, Miyazono K, Urabe A, Takaku F: Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL3, or erythropoietin. J Cell Physiol 140:323, 1989
16. Zhang M-Y, Clawson GA, Olivieri NF, Bell LL, Begley CG, Miller BA: Expression of SCL is normal in transfusion-dependent Diamond-Blackfan anemia but other bHLH proteins are deficient. Blood 90:2068, 1997
17. Schreiber E, Matthias P, Muller MM, Schaffner W: Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17:6419, 1989
18. Sun S-C, Ganchi PA, Ballard DW, Greene WC: NF-κB controls expression of inhibitor IκBα: Evidence for an inducible autoregulatory pathway. Science 259:1912, 1993
19. Stein B, Rahmsdorf H, Steffen A, Litfin M, Herrlich P: UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Mol Cell Biol 9:5169, 1989
20. Sun S-C, Elwood J, Greene WC: Both amino- and carboxyl-terminal sequences within IκBα regulate its inducible degradation. Mol Cell Biol 16:1058, 1996
21. Doerre S, Sista P, Sun S-C, Ballard DW, Greene WC: The c-rel protooncogene product represses NF-κB p65-mediated transcriptional activation of the long terminal repeat of type I human immunodeficiency virus. Proc Natl Acad Sci USA 90:1023, 1993
22. Ganchi PA, Sun S-C, Greene WC, Ballard DW: IκB/MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding. Mol Biol Cell 3:1339, 1992
23. Sun S-C, Ganchi PA, Beraud C, Ballard DW, Greene WC: Autoregulation of the NF-κB p65 transactivator by multiple ankyrinrich cytoplasmic inhibitors. Proc Natl Acad Sci USA 91:1346, 1994
24. Maggirwar SB, Harhaj EW, Sun S-C: Regulation of the interleukin-2 CD28-responsive element by NF-Atp and various NF-κB/Rel transcription factors. Mol Cell Biol 17:2605, 1997
25. Harhaj EW, Maggirwar SB, Good L, Sun S-C: CD28 mediates a potent costimulatory signal for rapid degradation of IκBβ which is associated with accelerated activation of various NF-κB/Rel heterodimers. Mol Cell Biol 16:6736, 1996
26. Sun S-C, Faye I: Affinity purification and characterization of CIF, an insect immunoresponsive factor with NF-κB-like properties. Comp Biochem Physiol 103(B):225, 1992
27. Zhang M-Y, Harhaj EW, Bell L, Sun S-C, Miller BA: Bcl-3 expression and nuclear translocation are induced by GM-CSF and Epo in proliferating human erythroid cells. (submitted)
28. Chrétien S, Varlet P, Verdier F, Gobert S, Cartron J-P, Gisselbrecht S, Mayeux P, Lacombe C: Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation. EMBO J 15:4174, 1996
29. Emilia G, Donelli A, Ferrari S, Torelli U, Selleri L, Zucchini P, Moretti L, Venturelli D, Ceccherelli G, Torelli G: Cellular levels of mRNA from c-myc, c-myb and c-fes onc-genes in normal myeloid and erythroid precursors of human bone marrow: An in situ hybridization study. Br J Haematol 62:287, 1986
30. Caracciolo D, Venturelli D, Valtieri M, Peschle C, Gewirtz AM, Calabretta B: Stage-related proliferative activity determines c-myb functional requirements during normal human hematopoiesis. J Clin Invest 85:55, 1990
31. Valtieri M, Venturelli D, Care A, Fossati, C, Pelosi E, Labbaye C, Mattia G, Gewirtz AM, Calabretta B, Peschle C: Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase α. Blood 77:1181, 1991
32. Kirsch IR, Bertness V, Silver J, Hollis GF: Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation. J Cell Biochem 32:11, 1986
33. Bondurant MC, Yamashita T, Muta K, Krantz SB, Koury MJ: c-myc Expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells. J Cell Physiol 168:255, 1996
34. Orkin SH: GATA-binding transcription factors in hematopoietic cells. Blood 80:575, 1992
35. Condorelli G, Vitelli L, Valtieri M, Marta I, Montesoro E, Lulli V, Baer R, Peschle C: Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation. Blood 86:164, 1995
36. Andrews NC, Erdjument-Bromage H, Davidson MB, Tempst P, Orkin SH: Erythroid transcription factor NF-E2 is a haematopoieticspecific basic-leucine zipper protein. Nature 362:722, 1993
37. Osada H, Grutz G, Axelson H, Forster A, Rabbitts TH: Association of erythroid transcription factors: Complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1. Proc Natl Acad Sci USA 92:9585, 1995
38. Feuillard J, Korner M, Israel A, Vassy J, Raphael M: Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ. Eur J Immunol 26:2547, 1996
39. Chang C-C, Zhang J, Lombardi L, Neri A, Dalla-Favera R: Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10. Oncogene 9:923, 1994
40. Ohno H, Takimoto G, McKeithan TW: The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60:991, 1990
41. Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, Siebenlist U: The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72:729, 1993
42. Fujita T, Nolan GP, Liou H-C, Scott ML, Baltimore D: The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev 7:1353, 1993
43. Pan J, McEver EP: Regulation of the human P-selection promoter by Bcl-3 and specific homodimeric members of the NF-κB/Rel family. J Biol Chem 270:23077, 1995
44. Nolan GP, Fujita T, Bhatia K, Kuppi C, Liou H-C, Scott ML, Baltimore D: The bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner. Mol Cell Biol 13:3357, 1993
45. Franzoso G, Bours V, Azarenko V, Park S, Tomita-Yamaguchi N, Kanno T, Brown K, Siebenlist U: The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select κB sites. EMBO J 12:3893, 1993
46. Falvo JV, Thanos D, Maniatis T: Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 83:1101, 1995
47. Beg AA, Sha WC, Bronson RT, Baltimore D: Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev 9:2736, 1995
48. Sha WC, Liou H-C, Tuomanen EI, Baltimore D: Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321, 1995
49. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D: Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167, 1995